Rubella Vaccine
Current screening program leaves women susceptible to infections
Published in Medical Letter on the CDC and FDA, December 18th, 2005
Researchers in the United States conducted a study "to estimate rubella, rubeola, and mumps (MMR) susceptibilities in pregnant women and determine the percentage not immune to rubeola or mumps, depending on rubella immunity status. A secondary objective was to assess costs of vaccination and testing programs aimed at eliminating these viral susceptibilities to determine an optimal strategy. This was an observational study of women presenting for prenatal care."
"All women had MMR antibody titers measured," said David M....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Epidemiology
Outcomes of health surveillance surveys vary with survey mode - Leishmaniasis
Visceral leishmaniasis spreads into Uttar Pradesh, India - Malaria Pathogenesis
Plasmodium ovale infection is reviewed - Pharmacokinetics
XK469 has low potential for active or toxic metabolites - Sexually Transmitted Disease
Syphilis partner notification is getting more difficult with men who have sex with men - Aflatoxin
Method for rapid extraction of aflatoxin from peanut butter is developed - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
